Liangcai Wu
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 5
- Cancer Genomics and Diagnostics 3
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis 2
-
- Colorectal Cancer Treatments and Studies 2
-
- Genetic factors in colorectal cancer 2
-
- Endometrial and Cervical Cancer Treatments 3
-
- RNA modifications and cancer 6
- Chromatin Remodeling and Cancer 2
- Co-authors
- Haitao ZhaoAnqiang WangXiaobo YangXueshuai WanJianzhen LinXinting SangHaohai ZhangChengpei Zhu
- Cited by
- Cancer ResearchHepatologyOncology
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Liangcai Wu
24 papers receiving 630 citations
Peers
Comparison fields: 5 of 77
- Cancer Research 200
- Hepatology 81
- Oncology 166
- Pathology and Forensic Medicine 80
- Obstetrics and Gynecology 33
Countries citing papers authored by Liangcai Wu
This map shows the geographic impact of Liangcai Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangcai Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangcai Wu more than expected).
Fields of papers citing papers by Liangcai Wu
This network shows the impact of papers produced by Liangcai Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangcai Wu. The network helps show where Liangcai Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Liangcai Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2022 | 4 | |
| 3 | 2020 | 5 | |
| 4 | 2020 | 19 | |
| 5 | 2019 | 15 | |
| 6 | 2019 | 3 | |
| 7 | 2018 | 32 | |
| 8 | 2018 | 68 | |
| 9 | 2017 | 23 | |
| 10 | 2017 | 84 | |
| 11 | 2017 | 32 | |
| 12 | 2017 | 8 | |
| 13 | 2017 | 20 | |
| 14 | 2016 | 10 | |
| 15 | 2016 | 67 | |
| 16 | 2016 | 4 | |
| 17 | 2016 | 19 | |
| 18 | 2016 | 25 | |
| 19 | 2016 | 35 | |
| 20 | 2007 | 15 |
About Liangcai Wu
Liangcai Wu is a scholar working on Cancer Research, Obstetrics and Gynecology and Hepatology, having authored 24 papers that have together received 635 indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (5 papers), Endometrial and Cervical Cancer Treatments (3 papers), Cancer Genomics and Diagnostics (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Genetic factors in colorectal cancer (2 papers) and Chromatin Remodeling and Cancer (2 papers). The work is most often cited by research in Cancer Research (200 citations), Hepatology (81 citations) and Oncology (166 citations). Liangcai Wu has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Haitao Zhao, Anqiang Wang, Xiaobo Yang, Xueshuai Wan, Jianzhen Lin, Xinting Sang, Haohai Zhang, Chengpei Zhu, Yuan Xie and Ruoyu Miao.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.